Valuation: Psychemedics Corporation

Market Cap 9.79M 8.61M 8.14M 7.39M 13.87M 940M 13.95M 97.5M 37.65M 480M 36.76M 35.96M 1.54B P/E 2023
-4.09x
P/E 2024 -7x
Enterprise Value 9.54M 8.39M 7.93M 7.2M 13.52M 916M 13.59M 95M 36.69M 467M 35.82M 35.04M 1.5B EV / Sales 2023
0.79x
EV / Sales 2024 0.68x
Free-Float
44.15%
Yield 2023
2.36%
Yield 2024 -
1 day+13.18%
6 months+55.79%
Current year+55.62%
Current year 1.33
Extreme 1.33
2.7
1 year 1.33
Extreme 1.33
2.7
3 years 1.11
Extreme 1.11
4
5 years 1.11
Extreme 1.11
8.9
10 years 1.11
Extreme 1.11
27.99
Manager TitleAgeSince
Chief Executive Officer 59 17/08/2023
Director of Finance/CFO 36 27/11/2023
Corporate Officer/Principal 40 21/09/2023
Director TitleAgeSince
Director/Board Member 64 16/03/2021
Director/Board Member 58 04/04/2022
Director/Board Member 64 12/08/2022
Date Insider Type Main position Quantity % Market Cap. Importance
12/13/24 A
Powell Anderson Capital Partners
BuyCompany 159,700 2.7093%
12/10/24 A
Powell Anderson Capital Partners
BuyCompany 86,991 1.4758%
12/10/24 A Sell

Director

320,708 5.4408%
Change 5-day change 1-year change 3-year change Capi.($)
+13.18%-.--%+18.01%-32.88% 15.26M
-0.15%+10.83%+151.87%+806.40% 59.47B
+0.12%-3.42%+9.64%+52.51% 25.11B
+1.17%-1.20%-10.12%-37.30% 6.52B
+1.23%-1.47%-4.15%+149.48% 5.57B
-0.52%+2.38%+21.59%+58.70% 3.4B
-3.33%-12.82%-25.14%+2,379.36% 2.64B
-0.59%-1.08%+147.10%+53.48% 2.48B
+15.04%-2.23%+33.15%+42.04% 2.27B
-1.29%+3.57%-0.51%-54.85% 2B
Average +2.48%-1.10%+34.14%+341.69% 10.95B
Weighted average by Cap. +0.20%+4.84%+87.97%+515.65%

Financials

2023 2024
Net sales 22.1M 19.44M 18.38M 16.67M 31.31M 2.12B 31.49M 220M 84.98M 1.08B 82.96M 81.17M 3.48B 19.68M 17.31M 16.37M 14.85M 27.89M 1.89B 28.05M 196M 75.7M 964M 73.91M 72.3M 3.1B
Net income -4.15M -3.65M -3.45M -3.13M -5.88M -399M -5.92M -41.36M -15.98M -203M -15.6M -15.26M -654M -1.86M -1.64M -1.55M -1.4M -2.64M -179M -2.65M -18.53M -7.16M -91.16M -6.99M -6.84M -293M
Net Debt 334K 294K 278K 252K 473K 32.06M 476K 3.33M 1.28M 16.36M 1.25M 1.23M 52.57M -251K -221K -209K -189K -356K -24.09M -358K -2.5M -965K -12.29M -942K -922K -39.51M
Logo Psychemedics Corporation
Psychemedics Corporation is a hair drug testing company. The Company provides testing services for the detection of drugs of abuse through the analysis of hair samples. Its testing methods utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. The Company customizes its enzyme immunoassay (EIA) procedures to drug test hair samples. It provides screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, phenylcyclohexyl piperidine (PCP), amphetamines (including ecstasy, eve, and Adderall), opiates (including heroin, hydrocodone, hydromorphone, oxycodone and codeine), synthetic cannabinoids (including K2, Spice, Blaze), benzodiazepines (Xanax, Valium, and Ativan), nicotine, Fentanyl, and alcohol. The Company markets its corporate drug testing services through its own sales force, distributors, and partners. It markets its home drug testing service, PDT-90, through the Internet.
Employees
101
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. PMDI Stock